Search

Patrick M. Fernandes

Examiner (ID: 8787, Phone: (571)272-7706 , Office: P/3736 )

Most Active Art Unit
3791
Art Unit(s)
3736, 3791
Total Applications
613
Issued Applications
344
Pending Applications
74
Abandoned Applications
222

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14569467 [patent_doc_number] => 20190212340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES [patent_app_type] => utility [patent_app_number] => 16/336074 [patent_app_country] => US [patent_app_date] => 2017-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336074 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/336074
AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES Sep 26, 2017 Abandoned
Array ( [id] => 15365997 [patent_doc_number] => 20200018763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => METHODS TO ASSESS BINDING AGENT SPECIFICITY [patent_app_type] => utility [patent_app_number] => 16/335774 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335774 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/335774
METHODS TO ASSESS BINDING AGENT SPECIFICITY Sep 25, 2017 Abandoned
Array ( [id] => 17098172 [patent_doc_number] => 20210285963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage [patent_app_type] => utility [patent_app_number] => 16/338729 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10780 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338729 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/338729
Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage Sep 25, 2017 Abandoned
Array ( [id] => 17621189 [patent_doc_number] => 11340237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Metabolite biomarkers for diseases associated with the contact activation system [patent_app_type] => utility [patent_app_number] => 16/333101 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 15778 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333101 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333101
Metabolite biomarkers for diseases associated with the contact activation system Sep 14, 2017 Issued
Array ( [id] => 14749327 [patent_doc_number] => 20190257837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => Nidogen-1 Fragments Assay [patent_app_type] => utility [patent_app_number] => 16/333444 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5607 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333444 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333444
Nidogen-1 Fragments Assay Sep 12, 2017 Abandoned
Array ( [id] => 16957174 [patent_doc_number] => 11061027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Materials and methods for evaluating and treating cancer [patent_app_type] => utility [patent_app_number] => 16/334978 [patent_app_country] => US [patent_app_date] => 2017-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 13 [patent_no_of_words] => 7921 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334978 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/334978
Materials and methods for evaluating and treating cancer Sep 11, 2017 Issued
Array ( [id] => 14627379 [patent_doc_number] => 20190227057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => MOLECULAR SENSORS [patent_app_type] => utility [patent_app_number] => 16/331327 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331327 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331327
Molecular sensors Sep 7, 2017 Issued
Array ( [id] => 15165647 [patent_doc_number] => 10488308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Preparation of lipemic plasma or serum samples for the determination of a lipid interference [patent_app_type] => utility [patent_app_number] => 15/698618 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5298 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698618 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/698618
Preparation of lipemic plasma or serum samples for the determination of a lipid interference Sep 6, 2017 Issued
Array ( [id] => 12794959 [patent_doc_number] => 20180156822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => BIOMARKER FOR CARDIAC DISORDERS [patent_app_type] => utility [patent_app_number] => 15/698554 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18077 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698554 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/698554
BIOMARKER FOR CARDIAC DISORDERS Sep 6, 2017 Abandoned
Array ( [id] => 13703427 [patent_doc_number] => 20170362668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => CO-BINDER ASSISTED ASSAY METHODS [patent_app_type] => utility [patent_app_number] => 15/696953 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9103 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15696953 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/696953
Co-binder assisted assay methods Sep 5, 2017 Issued
Array ( [id] => 12680905 [patent_doc_number] => 20180118801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 15/695812 [patent_app_country] => US [patent_app_date] => 2017-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695812 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/695812
COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES Sep 4, 2017 Abandoned
Array ( [id] => 12329592 [patent_doc_number] => 09945854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies [patent_app_type] => utility [patent_app_number] => 15/693679 [patent_app_country] => US [patent_app_date] => 2017-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10265 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693679 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/693679
Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies Aug 31, 2017 Issued
Array ( [id] => 13705387 [patent_doc_number] => 20170363648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => Biosensors Engineered from Conditionally Stable Ligand-Binding Domains [patent_app_type] => utility [patent_app_number] => 15/692211 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7828 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692211 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/692211
Biosensors Engineered from Conditionally Stable Ligand-Binding Domains Aug 30, 2017 Abandoned
Array ( [id] => 14870813 [patent_doc_number] => 20190285648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER [patent_app_type] => utility [patent_app_number] => 16/328846 [patent_app_country] => US [patent_app_date] => 2017-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328846 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/328846
NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER Aug 29, 2017 Abandoned
Array ( [id] => 13691903 [patent_doc_number] => 20170356906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT [patent_app_type] => utility [patent_app_number] => 15/685206 [patent_app_country] => US [patent_app_date] => 2017-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685206 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/685206
NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT Aug 23, 2017 Abandoned
Array ( [id] => 17681876 [patent_doc_number] => 11366124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-21 [patent_title] => Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers [patent_app_type] => utility [patent_app_number] => 16/326737 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 4 [patent_no_of_words] => 10769 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326737 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/326737
Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers Aug 22, 2017 Issued
Array ( [id] => 14504473 [patent_doc_number] => 20190195891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES [patent_app_type] => utility [patent_app_number] => 16/325393 [patent_app_country] => US [patent_app_date] => 2017-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325393 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/325393
DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES Aug 17, 2017 Abandoned
Array ( [id] => 18316028 [patent_doc_number] => 11630103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-18 [patent_title] => Product and methods useful for modulating and evaluating immune responses [patent_app_type] => utility [patent_app_number] => 16/325807 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 59 [patent_no_of_words] => 153327 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325807 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/325807
Product and methods useful for modulating and evaluating immune responses Aug 16, 2017 Issued
Array ( [id] => 13719935 [patent_doc_number] => 20170370922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => FLUIDIC DEVICE, SYSTEM, AND METHOD [patent_app_type] => utility [patent_app_number] => 15/679816 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15413 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679816 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/679816
Fluidic device, system, and method Aug 16, 2017 Issued
Array ( [id] => 12157345 [patent_doc_number] => 20180028610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'METHODS FOR DETECTING CARDIAC DAMAGE' [patent_app_type] => utility [patent_app_number] => 15/674053 [patent_app_country] => US [patent_app_date] => 2017-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11163 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674053 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/674053
Methods for detecting cardiac damage Aug 9, 2017 Issued
Menu